...
首页> 外文期刊>Regulatory Toxicology and Pharmacology: RTP >Towards AOP application - Implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization
【24h】

Towards AOP application - Implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization

机译:面向AOP应用程序-将集成的测试和评估方法(IATA)实施到用于皮肤敏化的管道工具中

获取原文
获取原文并翻译 | 示例
           

摘要

Since the OECD published the Adverse Outcome Pathway (AOP) for skin sensitization, many efforts have focused on how to integrate and interpret nonstandard information generated for key events in a manner that can be practically useful for decision making. These types of frameworks are known as Integrated Approaches to Testing and Assessment (IATA). Here we have outlined an IATA for skin sensitization which focuses on existing information including non testing approaches such as QSAR and read-across. The IATA was implemented into a pipeline tool using OASIS technology to provide a means of systematically collating and compiling relevant information which could be used in an assessment of skin sensitization potential. A test set of 100 substances with available skin sensitization information was profiled using the pipeline IATA. In silico and in chemico profiling information alone was able to correctly predict skin sensitization potential, with a preliminary accuracy of 73.85%. Information from other relevant endpoints (e.g., Ames mutagenicity) was found to improve the accuracy (to 87.6%) when coupled with a reaction chemistry mechanistic understanding. This pipeline platform could be useful in the assessment of skin sensitization potential and marks a step change in how non testing approaches can be practically applied.
机译:自从经合组织发布了对皮肤过敏的不良结果途径(AOP)以来,许多工作都集中在如何整合和解释为关键事件生成的非标准信息上,从而对决策产生实际的帮助。这些类型的框架被称为测试和评估集成方法(IATA)。在这里,我们概述了用于皮肤致敏的IATA,重点是现有信息,包括非测试方法(例如QSAR和交叉读取)。国际航协已使用OASIS技术实施到管道工具中,以提供一种系统地整理和汇编相关信息的手段,这些信息可用于评估皮肤致敏性。使用管道IATA对包含可用皮肤致敏信息的100种物质的测试集进行了分析。仅在计算机分析和化学分析中,信息就能正确预测皮肤致敏潜力,初步准确性为73.85%。当与反应化学机理的理解相结合时,发现来自其他相关终点的信息(例如,Ames致突变性)可提高准确性(至87.6%)。该管道平台可用于评估皮肤致敏潜力,并标志着非测试方法的实际应用方式迈出了一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号